AVDV vs IBB
Avantis International Small Cap Value ETF vs iShares Biotechnology ETF
- • AVDV has the lower expense ratio at 0.36% vs 0.44% for IBB.
- • AVDV pays a higher dividend yield (3.30%).
Side-by-side metrics
| Metric | AVDV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.36% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.30% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $19.67B | $11.50B |
YTD return | 14.66% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 0.60 |
P/E ratio | 11.93 | 25.48 |
Last price | $105.61 | $217.75 |
Inception | — | — |
Issuer | Avantis | iShares |
AVDV top holdings
| WTB.L | Whitbread PLC | 0.73% |
| ATS.VI | AT&S Austria Technologie & Systemtechnik AG | 0.69% |
| PRU.AX | Perseus Mining Ltd | 0.64% |
| BGEO.L | Lion Finance Group PLC | 0.58% |
| TVE.TO | Tamarack Valley Energy Ltd | 0.58% |
| CLIS.TA | Clal Insurance Enterprises Holdings Ltd | 0.58% |
| JMAT.L | Johnson Matthey PLC | 0.56% |
| TRMD-A.CO | TORM PLC Class A | 0.55% |
| BRBY.L | Burberry Group PLC | 0.55% |
| BTO.TO | B2Gold Corp | 0.55% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About AVDV
AVDV (Avantis International Small Cap Value ETF) is International developed small-cap value stocks. Managed by Avantis, the fund carries $19.7B in assets under management, an expense ratio of 0.36%, a dividend yield of 3.30%. Its largest holding is Whitbread PLC (WTB.L), which represents 0.7% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.